The Dutch Competition Authority conducts further investigations into whether the acquisition of a healthcare clinic could lead to higher prices for health insurers (Mauritskliniek / Bergman)
Further investigation needed into the acquisition of Mauritskliniek by Bergman Clinics*
The Netherlands Authority for Consumers and Markets (ACM) has not yet cleared the acquisition of health care provider Mauritskliniek by rival provider Bergman Clinics. ACM wishes to conduct a further investigation into whether this acquisition could lead to higher prices for health insurers. That is why Bergman
Access to this article is restricted to subscribers
Already Subscribed? Sign-in